WT161

WT161 Suppliers list
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel:
Email: sales@boylechem.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: HangZhou YuHao Chemical Technology Co., Ltd.  
Tel: 0571-82693216
Email: info@yuhaochemical.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com

WT161 manufacturers

  • WT-161
  • WT-161 pictures
  • $30.00
  • 2026-07-17
  • CAS:1206731-57-8
  • Purity: 99.01%
  • Supply Ability: 10g
WT161 Basic information
Product Name:WT161
Synonyms:WT-III-161;WT161; WT 161;CS-2547;Octanoic acid, 8-(hydroxyamino)-8-oxo-, 2-[[4-(diphenylamino)phenyl]methylene]hydrazide;Histone deacetylases,WT161,Inhibitor,inhibit,Apoptosis,WT-161,WT 161,HDAC;8-(2-(4-(Diphenylamino)benzylidene)hydrazinyl)-N-hydroxy-8-oxooctanamide;WT-161, 10 mM in DMSO;WT161 ,S8495
CAS:1206731-57-8
MF:C27H30N4O3
MW:458.55
EINECS:
Product Categories:API
Mol File:1206731-57-8.mol
WT161 Structure
WT161 Chemical Properties
density 1.15±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 10 mg/ml; DMSO: 10 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.33 mg/ml
form A crystalline solid
pka9.48±0.20(Predicted)
color White to off-white
Safety Information
MSDS Information
WT161 Usage And Synthesis
DefinitionChEBI: LSM-6269 is a tertiary amine.
Biological ActivityWT161 is a potent and selective HDAC6 inhibitor with IC50 values of 0.4 nM, 8.35 nM and 15.4 nM for HDAC6, HDAC1 and HDAC2, respectively, which is more than 100-fold selective for other HDACs.
in vitro

WT161 can selectively inhibit HDAC6 and significantly increase the level of acetylated α-tubulin, with little effect on the overall lysine acetylation. It is able to induce accumulation and toxicity of acetylated tubulin in multiple myeloma cells. WT161 alone did not induce ER stress response, UPR, or ER stress-related apoptosis. In cultured MCL JeKo-1 and Z138 cells, treatment with WT-161 increased intracellular ubiquitinated protein levels. WT-161 dose-dependently depletes cyclin D1 levels in cultured MCL cells (mantle cell lymphoma). Treatment of WT-161 also induced ER stress response in MCL cells-GRP78 protein level, phosphorylated eIF2α level increased, and pro-apoptotic transcription factor CHOP was induced. WT161 induced apoptotic cell death in MCF7, T47D, BT474 and MDA-MB231 cells, and decreased the expression of EGFR, HER2, ERα and downstream signals.

in vivo

WT161 has a reasonable half-life (1.4 hours) and drug exposure (Cmax=18 mg/L) in mice. It was well tolerated when administered as a single agent. It significantly inhibited the growth of MCF7 cells in vivo and down-regulated the expression of ERα in a xenograft tumor mouse model.

target< td style="border-bottom: 1px dotted #ccc;padding: 5px;"> HDAC2
(Cell-free assay)
TargetValue
HDAC6
(Cell-free assay)
0.4 nM
HDAC1
(Cell-free assay)
8.35 nM
15.4 nM
WT161 Preparation Products And Raw materials
Tag:WT161(1206731-57-8) Related Product Information
WT161 N,N'-bis[(E)-[4-(dimethylamino)phenyl]methylideneamino]decanediamide Crebinostat 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, N-[4-[[(2-aminophenyl)amino]carbonyl]phenyl]-4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S)- Citarinostat Hexanamide, 6-[4-(1,4,5,6,7,8-hexahydro-7-methyl-4-oxopyrido[4',3':4,5]thieno[2,3-d]pyrimidin-2-yl)-2,6-dimethylphenoxy]-N-hydroxy-